Arkin Bio

Arkin Bio Overview

Arkin Bio is an activity of Arkin Capital, a multi-billion-dollar VC, PE and Hedge Funds manager, targeting both early-stage and late-stage investments in Israel and around the world. They strategically invest through four main arms – Arkin Health, Arkin Equity, Arkin Tech, and Arkin Real Estate – covering 10 core investment activities and eight dedicated funds. Arkin Bio Ventures identifies, invests in, and accompanies innovative early and mid-stage companies with game-changing breakthroughs in areas such as immunotherapy, cancer, metabolism, microbiome, central nervous system, autoimmune diseases, orphan diseases, and drug-delivery platforms. Arkin Bio Ventures' management team leads and supports its portfolio companies through the hurdles of drug development, towards the proof-of-concept stage and beyond, to significant value creation. Arkin Bio Ventures is currently invested in companies in various stages of product development. Arkin Bio Ventures is a joint venture between insurance and finance company Phoenix Group (49%) and Arkin Holdings (51%). In 2016, the two companies announced a strategic collaboration agreement for investment in pharmaceutical and biotechnology companies, for a total of approximately $60 million (with an option to increase the investment in the future).

Latest News

Mar 9, 2020 · www.fiercebiotech.com

N/A

https://www.fiercebiotech.com/biotech/arkin-holdings-phoenix-group-unite-again-140m-biotech-fund

The article does not provide any information about Questex LLC or any relevant events.

Jun 16, 2016 · www.prnewswire.com

growth-positive

Arkin Holdings and Phoenix Group Announce a Strategic Collaboration That Will Invest Approximately $60 Million in Pharma and Biotech Companies

Phoenix Group and Arkin Holdings have announced a Strategic Collaboration Agreement for investment in pharma and biotech companies, totalling approximately $60 million. The new partnership, Arkin Bio-Ventures, aims to invest in companies that develop promising innovative pharmaceuticals in pre-clinical and more advanced stages, both in Israel and globally. This is the largest investment ever made by the Phoenix Group in private pharma companies, and the first time its Investment Division promotes such an extensive life science collaboration.

InvestmentPartners

Team Members

4

Web & Social Links

Locations

Ha-Menofim St 11, Herzliya, Israel

Photos & Videos

No files yet

Arkin Bio Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info